View in EDS HTML Full Text PDF Full Text

An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany.

Saved in:
Bibliographic Details
Title: An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany.
Authors: Raitner I; Sandoz Deutschland/Hexal AG, Holzkirchen, Germany., Müller B; Sandoz Deutschland/Hexal AG, Holzkirchen, Germany., Vijayan A; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany., Zimmermann L; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany., Bramlage P; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany., Ness NH; Sandoz Deutschland/Hexal AG, Holzkirchen, Germany., Müller M; Sandoz Deutschland/Hexal AG, Holzkirchen, Germany.
Source: Frontiers in public health [Front Public Health] 2025 Dec 16; Vol. 13, pp. 1667315. Date of Electronic Publication: 2025 Dec 16 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41477238
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Raitner+I%22">Raitner I</searchLink>; Sandoz Deutschland/Hexal AG, Holzkirchen, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+B%22">Müller B</searchLink>; Sandoz Deutschland/Hexal AG, Holzkirchen, Germany.<br /><searchLink fieldCode="AU" term="%22Vijayan+A%22">Vijayan A</searchLink>; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Zimmermann+L%22">Zimmermann L</searchLink>; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bramlage+P%22">Bramlage P</searchLink>; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ness+NH%22">Ness NH</searchLink>; Sandoz Deutschland/Hexal AG, Holzkirchen, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+M%22">Müller M</searchLink>; Sandoz Deutschland/Hexal AG, Holzkirchen, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101616579%22">Frontiers in public health</searchLink> [Front Public Health] 2025 Dec 16; Vol. 13, pp. 1667315. <i>Date of Electronic Publication: </i>2025 Dec 16 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Editorial+Office%22">Frontiers Editorial Office </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101616579 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2296-2565 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222962565%22">22962565 </searchLink><i>NLM ISO Abbreviation: </i>Front Public Health <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41477238
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fpubh.2025.1667315
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1667315
    Titles:
      – TitleFull: An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Raitner I
      – PersonEntity:
          Name:
            NameFull: Müller B
      – PersonEntity:
          Name:
            NameFull: Vijayan A
      – PersonEntity:
          Name:
            NameFull: Zimmermann L
      – PersonEntity:
          Name:
            NameFull: Bramlage P
      – PersonEntity:
          Name:
            NameFull: Ness NH
      – PersonEntity:
          Name:
            NameFull: Müller M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 12
              Text: 2025 Dec 16
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2296-2565
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in public health
              Type: main
ResultId 1